Aclaris therapeutics, inc. (ACRS)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Dec'14
Assets
Current assets:
Cash, cash equivalents and restricted cash

53,992

35,937

29,898

31,654

34,197

57,019

26,590

46,035

-

20,202

-

-

-

-

-

-

-

-

-

-

Cash and cash equivalents

-

-

-

-

-

-

-

-

54,881

-

60,055

32,708

23,677

30,171

17,796

31,815

13,131

9,851

25,419

10,757

Marketable securities

25,013

39,078

61,530

83,863

102,558

110,953

107,681

118,569

132,096

173,655

167,793

137,789

129,741

107,051

66,246

62,195

72,115

75,017

12,986

5,373

Accounts receivable, net

933

704

673

19,370

15,817

563

1,033

2,182

529

481

658

-

-

-

-

-

-

-

-

-

Inventory

-

-

189

185

856

791

1,044

1,026

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

2,776

3,118

2,089

2,822

3,385

4,802

9,171

3,360

4,750

5,883

5,616

5,254

3,931

1,334

1,548

1,628

1,587

1,656

955

204

Discontinued operations - current assets

-

4,966

51,180

-

-

6,162

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

82,714

83,803

145,370

137,894

156,813

179,499

145,519

171,172

192,256

200,221

234,122

175,751

157,349

138,556

85,590

95,638

86,833

86,524

39,360

16,334

Marketable securities

-

-

-

-

-

-

-

-

-

14,997

-

-

8,019

36,912

-

-

-

7,170

-

518

Property and equipment, net

2,187

2,470

2,854

4,241

4,026

2,287

4,409

4,375

2,191

2,159

1,203

938

706

481

461

434

417

360

761

515

Intangible assets

7,180

7,199

7,217

69,781

71,459

7,274

7,292

7,311

7,330

7,349

7,367

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

18,504

18,504

18,504

18,504

18,504

18,504

18,504

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

99

116

-

-

-

-

0

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,943

-

Other assets

4,731

4,825

4,975

5,323

2,381

332

452

457

341

279

195

20

20

136

20

20

20

22

23

10

Discontinued operations - non-current assets

-

-

-

-

-

67,670

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

96,812

98,297

160,416

217,239

253,183

275,566

176,176

201,819

220,622

243,509

261,391

176,808

166,210

176,085

86,071

96,092

87,270

94,076

42,087

17,377

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

6,946

9,917

17,780

14,160

14,574

11,675

13,735

12,504

8,155

7,822

6,483

5,848

3,604

2,845

1,774

3,309

2,808

810

958

1,263

Accrued expenses

10,374

7,721

6,066

27,597

20,786

8,088

8,545

7,565

5,668

4,940

3,510

2,521

2,033

3,378

2,817

2,198

921

745

939

188

Current portion of lease liabilities

624

637

642

991

868

142

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations - current liabilities

2,659

4,157

14,501

-

-

7,437

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

20,603

22,432

38,989

42,748

36,228

27,342

22,280

20,069

13,823

12,762

9,993

8,369

5,637

6,223

4,591

5,507

3,729

1,555

1,897

1,451

Other liabilities

3,477

3,736

4,005

5,120

3,301

476

1,775

1,754

534

558

375

-

-

372

-

-

-

-

-

-

Long-term debt, net

10,573

-

29,930

29,924

29,918

29,914

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration

3,435

1,668

1,668

1,668

934

934

5,244

5,244

5,244

4,378

4,378

-

-

-

-

-

-

-

-

-

Deferred tax liability

549

549

-

-

-

549

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

549

549

549

-

549

549

549

549

2,386

-

-

-

-

-

-

-

-

-

Discontinued operations - non-current liabilities

-

-

-

-

-

1,227

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

295

284

-

358

345

330

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

4

Total liabilities

38,637

28,385

75,141

80,009

70,930

60,442

29,848

27,616

20,150

18,247

17,132

8,664

5,921

6,595

4,949

5,852

4,059

1,555

1,900

1,455

Commitments and contingencies (Note 10)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Convertible preferred stock (Series A, B and C), $0.00001 par value; 34,090,000 shares authorized at December 31, 2014; 27,341,057 shares issued and outstanding at December 31, 2014; aggregate liquidation preference of $35,882 at December 31, 2014

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

78,305

36,677

Stockholders' Equity:
Preferred stock, $0.00001 par value; 10,000,000 shares authorized and no shares issued or outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

-

0

-

0

Common stock, $0.00001 par value; 100,000,000 shares authorized at March 31, 2020 and December 31, 2019; 41,832,220 and 41,485,638 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

-

Additional paid-in capital

527,241

523,505

520,209

516,836

512,040

507,366

400,066

395,273

390,464

384,943

380,873

286,619

264,009

260,671

160,613

158,982

139,080

135,503

0

-

Accumulated other comprehensive income (loss)

47

-66

-1

8

-49

-69

-116

-188

-328

-246

-113

-166

-249

-269

-54

1

3

-149

1

-6

Accumulated deficit

-469,113

-453,527

-434,933

-379,614

-329,738

-292,173

-253,622

-220,882

-189,664

-159,435

-136,501

-118,309

-103,471

-90,912

-79,437

-68,743

-55,872

-42,833

-38,119

-20,749

Total stockholders’ equity

58,175

69,912

85,275

137,230

182,253

215,124

146,328

174,203

200,472

225,262

244,259

168,144

160,289

169,490

81,122

90,240

83,211

92,521

-38,118

-20,755

Total liabilities and stockholders’ equity

96,812

98,297

160,416

217,239

253,183

275,566

176,176

201,819

220,622

243,509

261,391

176,808

166,210

176,085

86,071

96,092

87,270

94,076

42,087

17,377